GB1182124A — Process for the production of Pharmaceutical and like Beadlets
Assigned to Individual · Expires 1970-02-25 · 56y expired
What this patent protects
1,182,124. Pharmaceutical &c. beadlets. W. E. GAUNT. 5 May, 1967, No. 20981/67. Headings A5B and A5E. Small, spherical beads of substantially identical size and composition and containing at least one pharmaceutically or biochemically active ingredient are prepared by allowin…
USPTO Abstract
1,182,124. Pharmaceutical &c. beadlets. W. E. GAUNT. 5 May, 1967, No. 20981/67. Headings A5B and A5E. Small, spherical beads of substantially identical size and composition and containing at least one pharmaceutically or biochemically active ingredient are prepared by allowing drops of a solvent or solvent mixture to fall on a bed of finely divided polymer which is readily soluble in the solvent. The spherical beads formed are screened out of the bed subsequently and dried. Specified polymers are: cellulose acetate phthalate, carboxy polymethylene and carboxylated polyvinyl acetate co-polymers. The active compound, which may be present in the solvent or the polymer bed, may be a medicament such as a tranquilizer, antihistamine, steroid, anorectic, antibiotic, decongestant, antitussive, antichlorinergic, antibacterial or antifungal agent many examples of which are specified. Alternatively, it may be an agricultural chemical such as a herbicide e.g. phenyl mercuric acetate. The polymer bed may also contain a "cosubstance" which becomes entrapped in the beads and modifies their properties (particularly rate of release of the active substance). The "cosubstances" used are film-forming aluminium salts. When the active ingredient forms such an aluminium salt, this salt is used; when it is not, aluminium aspirin is used. Other aluminium salts mentioned are aluminium abietate, naphthenate and octoate.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.